Wang and colleagues demonstrated that daily intraperitoneal injections of the HDAC inhibitor trichostatin A (TSA) for 8 weeks significantly reduced fibrosis after MI in mice [59]. The gene discussed is HDAC9; the disease is myocardial infarction.